CLINICAL TRIALS PROFILE FOR SUBOXONE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for suboxone
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Formulation | NCT00637000 ↗ | Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone | Completed | Indivior Inc. | Phase 2 | 2008-03-01 | The purpose of this study is to compare the presence, degree, time course and profile of opioid withdrawal symptoms associated with induction onto new formulations of buprenorphine or buprenorphine/naloxone in persons with active opioid dependence. The primary outcome measure is the severity of withdrawal symptoms measured using the Clinical Opiate Withdrawal Scale (COWS). The primary study hypothesis is that neither drug formulation will precipitate an opioid withdrawal syndrome. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for suboxone
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000320 ↗ | Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 1/Phase 2 | 1997-10-01 | The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form." |
| NCT00078117 ↗ | Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 | Completed | University of California, Los Angeles | Phase 3 | 2003-06-01 | The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification. |
| NCT00249574 ↗ | Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 | Completed | Organization to Achieve Solutions in Substance Abuse (OASIS) | N/A | 2003-06-01 | The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine. |
| NCT00249574 ↗ | Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 | Completed | National Institute on Drug Abuse (NIDA) | N/A | 2003-06-01 | The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine. |
| NCT00367302 ↗ | Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release | Completed | National Institute on Drug Abuse (NIDA) | Phase 1/Phase 2 | 2006-08-01 | The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release. |
| NCT00367302 ↗ | Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release | Completed | New York City Department of Health and Mental Hygiene | Phase 1/Phase 2 | 2006-08-01 | The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for suboxone
Condition Name
Clinical Trial Locations for suboxone
Trials by Country
Clinical Trial Progress for suboxone
Clinical Trial Phase
Clinical Trial Sponsors for suboxone
Sponsor Name
